Skip to Main Content

Paper Details

Pharmacologic Inhibition of SHP2 Blocks Both PI3K and MEK Signaling in Low-epiregulin HNSCC via GAB1.
Cancer Res Commun
4
2022
GAB1, HNSCC, HNSCCs, HPV+ patient-derived xenograft, MEK, PDX, PI3K, RTK, RTKs, SHP099, SHP2, cancer, cancer cell lines, epiregulin, mTORC, mouse, patient, receptor tyrosine kinases, solid tumor, tyrosine
Author NameAffiliation
Mikhail G DozmorovVirginia Commonwealth University School of Medicine
Mikhail G DozmorovVirginia Commonwealth University
Cyril H BenesMassachusetts General Hospital Cancer Center, Harvard Medical School
  • 1 - 3

Datasets

Release 1.2